Restoration of menstruation after chemotherapy-induced amenorrhoea in a patient with ovarian immature teratoma.
We described a rare case of a 20-year-old woman with an ovarian immature teratoma who resumed regular spontaneous menses after more than 5 years of chemotherapy-induced amenorrhoea. Efforts to reverse chemotherapy-induced ovarian failure can be continued even after persistent menstrual dysfunction of 5 or more years.
Iha
T
T
Department of Obstetrics and Gynecology, Faculty of Medicine, University of the Ryukyus, 207 Uehara Nishihara-Machi, Nakagami-Gun, Okinawa, Japan.
Kano
M
M
Nakayama
M
M
Nagai
Y
Y
Moromizato
H
H
Kanazawa
K
K
D000328:Adult; D000568:Amenorrhea / Q000139:chemically induced*; D000970:Antineoplastic Agents / Q000009:adverse effects; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use; D008598:Menstruation; D010051:Ovarian Neoplasms / Q000150:complications / Q000188:drug therapy*; D010053:Ovary / Q000187:drug effects / Q000502:physiology; D013724:Teratoma / Q000150:complications / Q000188:drug therapy*
D000970:Antineoplastic Agents; D004967:Estrogens; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D017258:Medroxyprogesterone Acetate